Epinephrine Inhalation Aerosol USP (HFA-MDI)

epinephrine · Amphastar Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epinephrine Inhalation Aerosol USP (HFA-MDI), covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics [Phase 1, Phase 2]